Sale!

MSH3 Gene Familial Adenomatous Polyposis Type 4 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The MSH3 Gene Familial Adenomatous Polyposis Type 4 NGS Genetic DNA Test is a cutting-edge genetic screening that identifies mutations in the MSH3 gene associated with hereditary colorectal cancer syndromes. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect specific genetic variations that significantly increase the risk of developing familial adenomatous polyposis and related gastrointestinal cancers. Individuals with a family history of colorectal cancer, multiple polyps, or early-onset gastrointestinal tumors should consider this test for proactive health management. The test provides crucial information for personalized cancer prevention strategies and family planning decisions. Results are delivered within 3-4 weeks from blood or DNA samples. The discounted price is $500 USD, offering substantial savings from the regular $700 USD cost. Genetic counseling is included to help interpret results and develop appropriate surveillance plans.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MSH3 Gene Familial Adenomatous Polyposis Type 4 NGS Genetic DNA Test

Comprehensive Genetic Assessment for Hereditary Colorectal Cancer Risk

The MSH3 Gene Familial Adenomatous Polyposis Type 4 NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment. This advanced diagnostic tool specifically targets mutations in the MSH3 gene, which plays a critical role in DNA mismatch repair mechanisms. When MSH3 gene function is compromised, individuals face significantly elevated risks for developing familial adenomatous polyposis type 4 and related colorectal cancer syndromes.

What This Test Measures and Detects

Our state-of-the-art NGS (Next-Generation Sequencing) technology comprehensively analyzes the MSH3 gene to identify:

  • Pathogenic variants and mutations in the MSH3 gene sequence
  • Single nucleotide polymorphisms (SNPs) associated with cancer predisposition
  • Insertions, deletions, and copy number variations affecting gene function
  • Specific genetic markers linked to familial adenomatous polyposis type 4
  • DNA mismatch repair deficiencies that increase cancer susceptibility

Who Should Consider This Genetic Test

This comprehensive genetic screening is particularly recommended for individuals experiencing:

  • Family history of colorectal cancer or multiple gastrointestinal polyps
  • Personal history of early-onset colorectal cancer (before age 50)
  • Multiple adenomatous polyps detected during colonoscopy
  • Unexplained gastrointestinal symptoms with family cancer patterns
  • Relatives with confirmed MSH3 gene mutations
  • Concerns about hereditary cancer risk for family planning purposes

Significant Benefits of MSH3 Genetic Testing

Undergoing this advanced genetic assessment provides numerous advantages:

  • Early Risk Identification: Detect genetic predispositions before symptom onset
  • Personalized Surveillance: Develop tailored cancer screening schedules
  • Family Planning Guidance: Make informed decisions about genetic inheritance
  • Preventive Strategies: Implement proactive health measures based on genetic risk
  • Treatment Planning: Guide medical interventions for at-risk individuals
  • Peace of Mind: Reduce uncertainty about hereditary cancer risks

Understanding Your Test Results

Your comprehensive genetic report will include detailed interpretation of findings:

  • Positive Result: Indicates presence of MSH3 gene mutation requiring enhanced surveillance and preventive measures
  • Negative Result: Suggests no detected mutation, though continued routine screening may be recommended
  • Variant of Uncertain Significance: Identifies genetic changes requiring further research and monitoring
  • Professional Genetic Counseling: Included with all results to ensure proper understanding and next steps

Test Pricing and Details

Test Feature Details
Test Name MSH3 Gene Familial Adenomatous Polyposis Type 4 NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Accessibility Across the United States

We proudly serve patients throughout the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more cities. Our network of certified genetic counselors and medical professionals ensures consistent, high-quality care regardless of your location.

Take Control of Your Genetic Health Today

Don’t leave your hereditary cancer risk to chance. Our comprehensive MSH3 genetic testing provides the clarity and confidence you need for proactive health management. With our discounted pricing and nationwide availability, there’s never been a better time to invest in your genetic wellbeing.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your MSH3 Gene Familial Adenomatous Polyposis Type 4 NGS Genetic DNA Test. Our expert team is ready to guide you through every step of the process and help you understand your genetic cancer risk profile.